STIM

#3505
Neuronetics, Inc. - Common Stock
1.5 4 USD
-1.28%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.54
1.54
년간 변동
0.80
4.82
일일 변동
-1.28%
월간 변동
-9.41%
6달 변화
+3.36%
년간 변동율
-60.71%
이전 종가
1.5 6
Open
1.5 4
저가
1.5 4
High
1.5 4
양
33
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 107.17 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-2.34
주가매출액비율
0.65

Neuronetics, Inc. - Common Stock

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

뉴스